Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
Zheng F, Mai S, Cen X, Zhao P, Ye W, Ke J, Lin S, Hu H, Guo Z, Zhang S, Liao H, Wu T, Tian Y, Zhang Q, Pang J, Zhao Z.
Zheng F, et al. Among authors: liao h.
Bioorg Chem. 2024 Jun;147:107381. doi: 10.1016/j.bioorg.2024.107381. Epub 2024 Apr 23.
Bioorg Chem. 2024.
PMID: 38669781